Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 1/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8664986 | 0.86 | THRB (0.39) | THRBCYP2C9 | |
| SCHEMBL25509617 | 0.74 | HSD11B1 (0.34) | HSD11B1 | |
| SCHEMBL6339275 | 0.73 | — | — | |
| SCHEMBL28318267 | 0.72 | — | — | |
| SCHEMBL26746340 | 0.71 | SLC6A4 (0.41) | HSD11B1THRBCYP2C9 | |
| SCHEMBL3733593 | 0.71 | SLC6A4 (0.41) | HSD11B1THRBCYP2C9 | |
| SCHEMBL202772 | 0.71 | SLC6A4 (0.41) | HSD11B1THRBCYP2C9 | |
| SCHEMBL23057412 | 0.70 | HSD11B1 (0.32) | HSD11B1 | |
| SCHEMBL24064295 | 0.70 | HSD11B1 (0.32) | HSD11B1 | |
| SCHEMBL25509618 | 0.70 | HSD11B1 (0.35) | HSD11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0920307-A2 | DERIVATES FROM BISARYLTETRACARBONACID, AND PHARMARCEUTICAL PRODUCT CONTAINING THEM | Roche Diagnostics GmbH (DE) | 1999-06-09 | — | — | EP | claimed |
| WO-1998006386-A2 | DERIVATES FROM BISARYLTETRACARBONACID, AND PHARMARCEUTICAL PRODUCT CONTAINING THEM | ROCHE DIAGNOSTICS GMBH (DE) | 1998-02-19 | — | — | WO | claimed |
| EP-2276752-B1 | COMPOUND COMPOSED OF A METAL ION AND A MARKER PRECURSOR HAVING TWO OR MORE TARGETING VECTORS, AND USE OF THE COMPOUND | Johannes Gutenberg-Universität Mainz (DE) | 2017-07-26 | — | — | EP | disclosed |
| EP-2276752-A1 | COMPOUND COMPOSED OF A METAL ION AND A MARKER PRECURSOR HAVING TWO OR MORE TARGETING VECTORS, AND USE OF THE COMPOUND | Johannes Gutenberg-Universität Mainz (DE) | 2011-01-26 | — | — | EP | disclosed |
| WO-2010097374-A1 | COMPOUNDS FOR USE AS BRADYKININ B1 ANTAGONISTS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2010-09-02 | — | — | WO | disclosed |
| WO-2009124764-A1 | COMPOUND COMPOSED OF A METAL ION AND A MARKER PRECURSOR HAVING TWO OR MORE TARGETING VECTORS, AND USE OF THE COMPOUND | Johannes Gutenberg-Universität Mainz (DE) | 2009-10-15 | — | — | WO | disclosed |
| EP-1747217-A1 | NOVEL SUBSTITUTED THIOPHENECARBOXAMIDES, THEIR PRODUCTION AND THEIR USE AS MEDICAMENTS | Boehringer Ingelheim International GmbH (DE) | 2007-01-31 | — | — | EP | disclosed |
| WO-2005111029-A1 | NOVEL SUBSTITUTED THIOPHENECARBOXAMIDES, THEIR PRODUCTION AND THEIR USE AS MEDICAMENTS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2005-11-24 | — | — | WO | disclosed |
| EP-0920307-A2 | DERIVATES FROM BISARYLTETRACARBONACID, AND PHARMARCEUTICAL PRODUCT CONTAINING THEM | Roche Diagnostics GmbH (DE) | 1999-06-09 | — | — | EP | disclosed |
| EP-0846127-A1 | ACYLATED OLIGOPEPTIDE DERIVATIVES HAVING CELL SIGNAL INHIBITING ACTIVITY | Novartis AG (CH) | 1998-06-10 | — | — | EP | disclosed |
| WO-1998006386-A2 | DERIVATES FROM BISARYLTETRACARBONACID, AND PHARMARCEUTICAL PRODUCT CONTAINING THEM | ROCHE DIAGNOSTICS GMBH (DE) | 1998-02-19 | — | — | WO | disclosed |
| WO-1997008193-A1 | ACYLATED OLIGOPEPTIDE DERIVATIVES HAVING CELL SIGNAL INHIBITING ACTIVITY | NOVARTIS AG (CH) | 1997-03-06 | — | — | WO | disclosed |
| EP-0518088-A2 | Process for clostripain-catalysed coupling of Arg-Pro and Arg-B (B=proteinogenic or non proteinogenic amino acids) containing them | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-12-16 | — | — | EP | disclosed |